Legacy Private Trust Co. Has $3.37 Million Holdings in UnitedHealth Group Incorporated $UNH

Legacy Private Trust Co. boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 14.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,792 shares of the healthcare conglomerate’s stock after purchasing an additional 1,370 shares during the period. Legacy Private Trust Co.’s holdings in UnitedHealth Group were worth $3,367,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its stake in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares during the last quarter. IAG Wealth Partners LLC bought a new stake in UnitedHealth Group during the first quarter valued at $42,000. Copia Wealth Management acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $42,000. Finally, O Brien Wealth Partners LLC grew its stake in UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after purchasing an additional 37 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 0.3%

NYSE UNH opened at $352.61 on Monday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $319.35 billion, a P/E ratio of 15.28, a PEG ratio of 2.30 and a beta of 0.45. The business has a fifty day simple moving average of $291.98 and a 200 day simple moving average of $368.31. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the company earned $6.80 EPS. The business’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

UNH has been the subject of several recent analyst reports. HSBC reaffirmed a “reduce” rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. KeyCorp dropped their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Bank of America boosted their target price on UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a research report on Monday, August 18th. JPMorgan Chase & Co. decreased their price objective on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a report on Wednesday, August 6th. Finally, Barclays lifted their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.